Construction
of a vitamin E-based liposomal biomaterial and its
ability to deliver therapeutic genes selectively across liver cancer
cells are demonstrated herein. In humans, liver regulates the levels
of α-tocopherol, i.e., vitamin E, and hepatic cells carry the
machinery for its transport. To exploit the presence of tocopherol
transport protein, we have selected an efficient gene transfecting
α-tocopherol-based twin lipid bearing a hydroxyethylated headgroup
and octamethylene spacer (TH8S) for liposome formation. Also, based
on the abundancy of the low-density lipoprotein receptor (LDLr) on
the cellular surface in the case of hepatocellular carcinoma, anti-LDLr
monoclonal antibody is used to confer the targeting ability to liposomes.
A facile thiol–maleimide click chemistry is used for antibody
decoration on the liposomal surface. Selective delivery of reporter
and therapeutic genes (GFP and p53) to cells of hepatic origin was
observed using anti-LDLr-tagged TH8S liposomes. Cellular internalization
by receptor-mediated endocytosis renders the bioconjugate highly specific
as well as highly efficient. Compatibility of the designed material
with human blood points to its safety of use in systemic circulation
thereby highlighting its in vivo potential. Thus,
we report here a versatile biomaterial derived from an essential vitamin
that promises potential for targeted suicidal gene therapy.